NDC 73309-090-01 - Crizotinib

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 73309-090
Requested NDC: 73309-090-01
Package NDCs from labels: 73309-090-01
Manufacturer: BLUEBAY SHANDONG CO.,LTD
Effective date: 2020-03-09
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Crizotinib - BLUEBAY SHANDONG CO.,LTD	BLUEBAY SHANDONG CO.,LTD	2020-03-09	BULK INGREDIENT

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
73309-090-01	Crizotinib	10 g in 1 JAR	POWDER	10		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
73309-090	CRIZOTINIB POWDER [BLUEBAY SHANDONG CO.,LTD]	1	1 package rows	20200310_893c7747-7aa3-4660-a863-d89ded906ad7.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Xalkori	CRIZOTINIB	Pfizer Laboratories Div Pfizer Inc	2a51b0de-47d6-455e-a94c-d2c737b04ff7	2025-07-22	Warnings, Adverse reactions	Exact identifier unii: 53AH36668S

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.